{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 673828, "items": [{"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:58:28Z", "timestamp": 1574434708340}, "reference-count": 78, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Pharmacol Exp Ther"], "published-print": {"date-parts": [[2012, 3]]}, "DOI": "10.1124/jpet.111.187468", "type": "journal-article", "created": {"date-parts": [[2011, 12, 17]], "date-time": "2011-12-17T04:21:03Z", "timestamp": 1324095663000}, "page": "750-764", "source": "Crossref", "is-referenced-by-count": 10, "title": ["S32212, a Novel Serotonin Type 2C Receptor Inverse Agonist/\u03b12-Adrenoceptor Antagonist and Potential Antidepressant: I. A Mechanistic Characterization"], "prefix": "10.1124", "volume": "340", "author": [{"given": "Mark J.", "family": "Millan", "sequence": "first", "affiliation": []}, {"given": "Clotilde", "family": "Mannoury la Cour", "sequence": "additional", "affiliation": []}, {"given": "Benjamin", "family": "Chanrion", "sequence": "additional", "affiliation": []}, {"given": "Delphine S.", "family": "Dupuis", "sequence": "additional", "affiliation": []}, {"given": "Benjamin", "family": "Di Cara", "sequence": "additional", "affiliation": []}, {"given": "Val\u00e9rie", "family": "Audinot", "sequence": "additional", "affiliation": []}, {"given": "Didier", "family": "Cussac", "sequence": "additional", "affiliation": []}, {"given": "Adrian", "family": "Newman-Tancredi", "sequence": "additional", "affiliation": []}, {"given": "Maud", "family": "Kamal", "sequence": "additional", "affiliation": []}, {"given": "Jean A.", "family": "Boutin", "sequence": "additional", "affiliation": []}, {"given": "Ralf", "family": "Jockers", "sequence": "additional", "affiliation": []}, {"given": "Philippe", "family": "Marin", "sequence": "additional", "affiliation": []}, {"given": "Jo\u00ebl", "family": "Bockaert", "sequence": "additional", "affiliation": []}, {"given": "Olivier", "family": "Muller", "sequence": "additional", "affiliation": []}, {"given": "Anne", "family": "Dekeyne", "sequence": "additional", "affiliation": []}, {"given": "Gilbert", "family": "Lavielle", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[2011, 12, 16]]}, "reference": [{"key": "2019081411484753000_340.3.750.1", "DOI": "10.1016/j.pharmthera.2008.10.010", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.2", "first-page": "417", "article-title": "Pharmacology of penile erection", "volume": "53", "author": "Andersson", "year": "2001", "journal-title": "Pharmacol Rev"}, {"key": "2019081411484753000_340.3.750.3", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1111/j.1527-3458.2001.tb00198.x", "article-title": "A review of the pharmacological and clinical profile of mirtazapine", "volume": "7", "author": "Anttila", "year": "2001", "journal-title": "CNS Drug Rev"}, {"key": "2019081411484753000_340.3.750.4", "first-page": "1323", "article-title": "The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity", "volume": "114", "author": "Auclair", "year": "2010", "journal-title": "J Neurochem"}, {"key": "2019081411484753000_340.3.750.5", "DOI": "10.1016/S0898-6568(02)00030-X", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.6", "DOI": "10.1016/S0306-4522(99)00082-2", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.7", "DOI": "10.1016/S0079-6123(08)00914-X", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.8", "DOI": "10.1016/j.euroneuro.2009.01.015", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.9", "DOI": "10.1007/s00213-010-2097-z", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.10", "DOI": "10.1124/mol.107.041574", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.11", "DOI": "10.1016/0006-2952(73)90196-2", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.12", "DOI": "10.1016/j.ejphar.2008.07.040", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.13", "DOI": "10.1124/mol.56.5.1025", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.14", "DOI": "10.1007/s00210-001-0505-y", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.15", "DOI": "10.1038/nrd3140", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.16", "DOI": "10.1124/jpet.111.187534", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.17", "DOI": "10.1007/s00213-008-1177-9", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.18", "DOI": "10.1016/j.neuropharm.2006.05.012", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.19", "DOI": "10.1111/j.1755-5949.2010.00135.x", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.20", "DOI": "10.1523/JNEUROSCI.5723-07.2008", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.21", "DOI": "10.1016/j.neuropharm.2008.06.061", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.22", "DOI": "10.1089/15406580360545107", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.23", "DOI": "10.1002/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.24", "DOI": "10.1007/s11938-006-0034-3", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.25", "DOI": "10.1111/j.1601-183X.2007.00316.x", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.26", "DOI": "10.1016/j.physbeh.2004.08.018", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.27", "DOI": "10.1016/j.pnpbp.2004.05.026", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.28", "DOI": "10.1016/j.neuroscience.2006.11.004", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.29", "first-page": "1", "article-title": "In vivo gene modification elucidates subtype-specific functions of \u03b12-adrenergic receptors", "volume": "293", "author": "Kable", "year": "2000", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019081411484753000_340.3.750.30", "DOI": "10.1080/15622970902717024", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.31", "DOI": "10.1097/JCP.0b013e31819c76e9", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.32", "DOI": "10.1016/S0028-3908(97)00038-5", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.33", "DOI": "10.1007/s00210-008-0378-4", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.34", "DOI": "10.1091/mbc.E08-04-0422", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.35", "DOI": "10.1111/j.1460-9568.2009.06718.x", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.36", "DOI": "10.1016/j.neuroscience.2005.09.031", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.37", "DOI": "10.1111/j.1471-4159.2009.06356.x", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.38", "DOI": "10.1016/j.ejphar.2009.08.046", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.39", "DOI": "10.2515/therapie:2005065", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.40", "DOI": "10.1016/j.pharmthera.2005.11.006", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.41", "DOI": "10.1038/nrd3628", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.42", "DOI": "10.1046/j.1460-9568.2000.00982.x", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.43", "DOI": "10.1177/026988110001400202", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.44", "DOI": "10.1124/jpet.102.039867", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.45", "DOI": "10.1016/j.tips.2008.06.007", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.46", "DOI": "10.1017/S1461145710001045", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.47", "DOI": "10.1016/S0014-2999(97)89962-1", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.48", "DOI": "10.1016/j.tips.2010.09.004", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.49", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1093/sleep/31.1.34", "article-title": "Selective 5-HT2A and 5-HT6 receptor antagonists promote sleep in rats", "volume": "31", "author": "Morairty", "year": "2008", "journal-title": "Sleep"}, {"key": "2019081411484753000_340.3.750.50", "DOI": "10.1021/jm058225d", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.51", "DOI": "10.1016/S0014-2999(00)00317-4", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.52", "DOI": "10.1016/j.pbb.2009.09.018", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.53", "DOI": "10.1007/s00210-002-0562-x", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.54", "DOI": "10.1038/sj.bjp.0702751", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.55", "DOI": "10.1016/j.psychres.2008.06.042", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.56", "DOI": "10.1016/j.pharmthera.2006.07.002", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.57", "DOI": "10.1517/13543770902932934", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.58", "DOI": "10.1038/sj.npp.1300418", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.59", "DOI": "10.1124/mi.3.6.319", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.60", "DOI": "10.1017/S1461145707008255", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.61", "DOI": "10.1124/jpet.104.067306", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.62", "DOI": "10.1016/0014-2999(94)90643-2", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.63", "unstructured": "Serres F Millan MJ Sharp T (2011) Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel \u03b12-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine. Int J Neuropsychopharmacol http://dx.doi.org/10.1017/S1461145711000733 .", "DOI": "10.1017/S1461145711000733", "doi-asserted-by": "crossref"}, {"key": "2019081411484753000_340.3.750.64", "DOI": "10.1016/j.neuropharm.2006.07.024", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.65", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1016/j.tips.2009.09.002", "article-title": "Glutamate-based antidepressants: 20 years on", "volume": "30", "author": "Skolnick", "year": "2011", "journal-title": "Trends Pharmacol Neurosci"}, {"key": "2019081411484753000_340.3.750.66", "DOI": "10.1074/jbc.M000796200", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.67", "DOI": "10.1016/S0091-3057(01)00702-X", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.68", "DOI": "10.1038/npp.2009.72", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.69", "DOI": "10.1517/14656566.6.4.631", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.70", "DOI": "10.1016/j.pbb.2006.02.015", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.71", "DOI": "10.1074/jbc.M605415200", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.72", "DOI": "10.1111/j.1471-4159.2005.03161.x", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.73", "DOI": "10.1042/bj3210721", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.74", "DOI": "10.1016/j.euroneuro.2011.07.018", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.75", "first-page": "28", "article-title": "Multi- and single-target agents for major psychiatric diseases: therapeutic opportunities and challenges", "volume": "9", "author": "Wong", "year": "2008", "journal-title": "Curr Opin Investig Drugs"}, {"key": "2019081411484753000_340.3.750.76", "doi-asserted-by": "crossref", "first-page": "945", "DOI": "10.1016/S0306-4522(02)00367-6", "article-title": "\u03b12A and \u03b12C adrenoceptors on spinal neurones controlling penile erection", "volume": "114", "author": "Ya\u00efci", "year": "2002", "journal-title": "Neuroscience"}, {"key": "2019081411484753000_340.3.750.77", "DOI": "10.1016/j.neuropharm.2010.12.025", "doi-asserted-by": "publisher"}, {"key": "2019081411484753000_340.3.750.78", "DOI": "10.1523/JNEUROSCI.2309-09.2010", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Pharmacology and Experimental Therapeutics"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/jpet.111.187468", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 14]], "date-time": "2019-08-14T18:53:11Z", "timestamp": 1565808791000}, "score": 67.659515, "issued": {"date-parts": [[2011, 12, 16]]}, "references-count": 78, "journal-issue": {"published-online": {"date-parts": [[2012, 2, 14]]}, "published-print": {"date-parts": [[2012, 3]]}, "issue": "3"}, "alternative-id": ["10.1124/jpet.111.187468"], "URL": "http://dx.doi.org/10.1124/jpet.111.187468", "relation": {"cites": []}, "ISSN": ["0022-3565", "1521-0103"], "issn-type": [{"value": "0022-3565", "type": "print"}, {"value": "1521-0103", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:58:28Z", "timestamp": 1574434708352}, "reference-count": 76, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Pharmacol Exp Ther"], "published-print": {"date-parts": [[2012, 3]]}, "DOI": "10.1124/jpet.111.187534", "type": "journal-article", "created": {"date-parts": [[2011, 12, 17]], "date-time": "2011-12-17T04:21:03Z", "timestamp": 1324095663000}, "page": "765-780", "source": "Crossref", "is-referenced-by-count": 19, "title": ["S32212, a Novel Serotonin Type 2C Receptor Inverse Agonist/\u03b12-Adrenoceptor Antagonist and Potential Antidepressant: II. A Behavioral, Neurochemical, and Electrophysiological Characterization"], "prefix": "10.1124", "volume": "340", "author": [{"given": "Anne", "family": "Dekeyne", "sequence": "first", "affiliation": []}, {"given": "Mauricette", "family": "Brocco", "sequence": "additional", "affiliation": []}, {"given": "Florence", "family": "Loiseau", "sequence": "additional", "affiliation": []}, {"given": "Alain", "family": "Gobert", "sequence": "additional", "affiliation": []}, {"given": "Jean-Michel", "family": "Rivet", "sequence": "additional", "affiliation": []}, {"given": "Benjamin", "family": "Di Cara", "sequence": "additional", "affiliation": []}, {"given": "Thomas I.", "family": "Cremers", "sequence": "additional", "affiliation": []}, {"given": "Gunnar", "family": "Flik", "sequence": "additional", "affiliation": []}, {"given": "Kevin C. F.", "family": "Fone", "sequence": "additional", "affiliation": []}, {"given": "David J. G.", "family": "Watson", "sequence": "additional", "affiliation": []}, {"given": "Mariusz", "family": "Papp", "sequence": "additional", "affiliation": []}, {"given": "Trevor", "family": "Sharp", "sequence": "additional", "affiliation": []}, {"given": "Florence", "family": "Serres", "sequence": "additional", "affiliation": []}, {"given": "Raymond", "family": "Cespuglio", "sequence": "additional", "affiliation": []}, {"given": "Berend", "family": "Olivier", "sequence": "additional", "affiliation": []}, {"given": "Johnny S. W.", "family": "Chan", "sequence": "additional", "affiliation": []}, {"given": "Gilbert", "family": "Lavielle", "sequence": "additional", "affiliation": []}, {"given": "Mark J.", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[2011, 12, 16]]}, "reference": [{"key": "2019081411484770000_340.3.765.1", "DOI": "10.1146/annurev.psych.60.110707.163514", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.2", "DOI": "10.1016/j.pharmthera.2008.10.010", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.3", "DOI": "10.1016/S0079-6123(08)00925-4", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.4", "DOI": "10.1016/j.euroneuro.2008.07.011", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.5", "DOI": "10.1016/j.pnpbp.2010.10.019", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.6", "DOI": "10.1007/s00213-010-2097-z", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.7", "DOI": "10.1016/j.jad.2007.06.006", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.8", "DOI": "10.1016/j.jneumeth.2009.03.007", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.9", "DOI": "10.1016/j.neubiorev.2005.03.008", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.10", "DOI": "10.1038/nrd3140", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.11", "DOI": "10.1007/s00213-008-1177-9", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.12", "DOI": "10.1007/s00213-009-1519-2", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.13", "DOI": "10.1159/000104877", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.14", "DOI": "10.1111/j.1755-5949.2010.00135.x", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.15", "DOI": "10.1017/S1461145709991088", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.16", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1515/REVNEURO.2007.18.1.37", "article-title": "Insights into the role of dopamine receptor systems in learning and memory", "volume": "18", "author": "El-Ghundi", "year": "2007", "journal-title": "Rev Neurosci"}, {"key": "2019081411484770000_340.3.765.17", "DOI": "10.1124/jpet.102.046383", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.18", "DOI": "10.1016/j.jneumeth.2011.08.040", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.19", "DOI": "10.1007/BF02247386", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.20", "DOI": "10.1111/j.1440-1819.2010.02113.x", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.21", "DOI": "10.1038/npp.2010.104", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.22", "DOI": "10.1111/j.1601-183X.2007.00316.x", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.23", "DOI": "10.1016/j.yhbeh.2007.03.030", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.24", "DOI": "10.1016/j.pnpbp.2004.05.026", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.25", "DOI": "10.1097/JCP.0b013e31819c76e9", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.26", "DOI": "10.1016/j.bbr.2010.11.033", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.27", "DOI": "10.1007/s00213-008-1070-6", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.28", "DOI": "10.1016/S0306-4522(02)00185-9", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.29", "DOI": "10.1111/j.1460-9568.2009.06718.x", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.30", "DOI": "10.1016/j.neuroscience.2005.09.031", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.31", "DOI": "10.1007/s00213-007-0934-5", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.32", "DOI": "10.1016/j.tips.2009.01.004", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.33", "DOI": "10.1016/j.bbr.2004.08.004", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.34", "DOI": "10.1016/j.ejphar.2009.08.046", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.35", "DOI": "10.1002/hup.726", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.36", "DOI": "10.2515/therapie:2005065", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.37", "DOI": "10.1016/j.pharmthera.2005.11.006", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.38", "DOI": "10.1016/j.pharmthera.2010.06.002", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.39", "DOI": "10.1038/nrd3628", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.40", "DOI": "10.1016/S0014-2999(03)01275-5", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.41", "DOI": "10.1017/S1461145710000775", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.42", "first-page": "581", "article-title": "S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine", "volume": "298", "author": "Millan", "year": "2001", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019081411484770000_340.3.765.43", "DOI": "10.1177/026988110001400202", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.44", "first-page": "1206", "article-title": "S18616, a highly potent spiroimidazoline agonist at \u03b12-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine", "volume": "295", "author": "Millan", "year": "2000", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019081411484770000_340.3.765.45", "DOI": "10.1124/jpet.111.187468", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.46", "DOI": "10.1016/j.ejphar.2005.09.029", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.47", "DOI": "10.1002/syn.20054", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.48", "DOI": "10.1016/j.conb.2010.02.003", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.49", "DOI": "10.1152/jn.00226.2004", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.50", "DOI": "10.1016/j.pbb.2009.09.018", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.51", "DOI": "10.1177/0269881107083808", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.52", "DOI": "10.1016/j.tips.2011.01.003", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.53", "unstructured": "Paxinos G Watson C (1998) The Rat Brain in Stereotaxic Coordinates, Academic Press, London."}, {"key": "2019081411484770000_340.3.765.54", "DOI": "10.1016/j.brainres.2005.06.057", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.55", "DOI": "10.1038/sj.npp.1301574", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.56", "DOI": "10.1016/j.psyneuen.2009.04.018", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.57", "DOI": "10.1016/S0166-4328(02)00272-3", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.58", "DOI": "10.1146/annurev.neuro.051508.135535", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.59", "DOI": "10.1016/j.pbb.2008.07.011", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.60", "DOI": "10.1038/sj.bjp.0707005", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.61", "DOI": "10.2165/00003495-200868120-00002", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.62", "DOI": "10.1002/jnr.22080", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.63", "unstructured": "Serres F Millan MJ Sharp T (2011) Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel \u03b12-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine. Int J Neuropsychopharmacol http://dx.doi.org/10.1017/S1461145711000733 .", "DOI": "10.1017/S1461145711000733", "doi-asserted-by": "crossref"}, {"key": "2019081411484770000_340.3.765.64", "DOI": "10.1097/JCP.0b013e3181a5233f", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.65", "DOI": "10.1016/S0091-3057(01)00702-X", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.66", "DOI": "10.1038/npp.2009.72", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.67", "DOI": "10.1517/14656566.6.4.631", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.68", "DOI": "10.1007/s00213-005-2268-5", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.69", "DOI": "10.1007/s00213-004-2114-1", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.70", "DOI": "10.1007/s00213-009-1466-y", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.71", "DOI": "10.1038/nrn2614", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.72", "DOI": "10.1016/j.pbb.2006.02.015", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.73", "DOI": "10.1146/annurev.psych.56.091103.070307", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.74", "DOI": "10.1159/000087097", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.75", "DOI": "10.1016/j.neubiorev.2008.04.004", "doi-asserted-by": "publisher"}, {"key": "2019081411484770000_340.3.765.76", "DOI": "10.1523/JNEUROSCI.2309-09.2010", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Pharmacology and Experimental Therapeutics"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/jpet.111.187534", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 14]], "date-time": "2019-08-14T18:53:39Z", "timestamp": 1565808819000}, "score": 67.32911, "issued": {"date-parts": [[2011, 12, 16]]}, "references-count": 76, "journal-issue": {"published-online": {"date-parts": [[2012, 2, 14]]}, "published-print": {"date-parts": [[2012, 3]]}, "issue": "3"}, "alternative-id": ["10.1124/jpet.111.187534"], "URL": "http://dx.doi.org/10.1124/jpet.111.187534", "relation": {"cites": []}, "ISSN": ["0022-3565", "1521-0103"], "issn-type": [{"value": "0022-3565", "type": "print"}, {"value": "1521-0103", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:46:38Z", "timestamp": 1574095598657}, "reference-count": 60, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 3, 1]], "date-time": "1999-03-01T00:00:00Z", "timestamp": 920246400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropharmacology"], "published-print": {"date-parts": [[1999, 3]]}, "DOI": "10.1016/s0028-3908(98)00203-2", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T12:59:42Z", "timestamp": 1027601982000}, "page": "415-423", "source": "Crossref", "is-referenced-by-count": 40, "title": ["Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO60-0175: a pharmacological analysis"], "prefix": "10.1016", "volume": "38", "author": [{"given": "A.", "family": "Dekeyne", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Girardon", "sequence": "additional", "affiliation": []}, {"given": "M.J.", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuropharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0028390898002032?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0028390898002032?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 30]], "date-time": "2019-04-30T00:57:31Z", "timestamp": 1556585851000}, "score": 49.557457, "issued": {"date-parts": [[1999, 3]]}, "references-count": 60, "journal-issue": {"published-print": {"date-parts": [[1999, 3]]}, "issue": "3"}, "alternative-id": ["S0028390898002032"], "URL": "http://dx.doi.org/10.1016/s0028-3908(98)00203-2", "ISSN": ["0028-3908"], "issn-type": [{"value": "0028-3908", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T18:18:40Z", "timestamp": 1575310720410}, "reference-count": 97, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2008, 10, 1]], "date-time": "2008-10-01T00:00:00Z", "timestamp": 1222819200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropsychopharmacol"], "published-print": {"date-parts": [[2009, 3]]}, "DOI": "10.1038/npp.2008.176", "type": "journal-article", "created": {"date-parts": [[2008, 10, 1]], "date-time": "2008-10-01T15:12:00Z", "timestamp": 1222873920000}, "page": "1039-1056", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Neurokinin1 Antagonists Potentiate Antidepressant Properties of Serotonin Reuptake Inhibitors, Yet Blunt Their Anxiogenic Actions: A Neurochemical, Electrophysiological, and Behavioral Characterization"], "prefix": "10.1038", "volume": "34", "author": [{"given": "Alain", "family": "Gobert", "sequence": "first", "affiliation": []}, {"given": "Mauricette", "family": "Brocco", "sequence": "additional", "affiliation": []}, {"given": "Anne", "family": "Dekeyne", "sequence": "additional", "affiliation": []}, {"given": "Benjamin", "family": "Di Cara", "sequence": "additional", "affiliation": []}, {"given": "Ga\u00eblle", "family": "Bouchez", "sequence": "additional", "affiliation": []}, {"given": "Fran\u00e7oise", "family": "Lejeune", "sequence": "additional", "affiliation": []}, {"given": "Robert L", "family": "Gannon", "sequence": "additional", "affiliation": []}, {"given": "Mark J", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 10, 1]]}, "reference": [{"key": "BFnpp2008176_CR1", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1016/j.neubiorev.2004.05.001", "volume": "28", "author": "A Adell", "year": "2004", "unstructured": "Adell A, Artigas F (2004). The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci Biobehav Rev 28: 415\u2013431.", "journal-title": "Neurosci Biobehav Rev"}, {"key": "BFnpp2008176_CR2", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1016/j.pharmthera.2006.08.004", "volume": "113", "author": "KD Alex", "year": "2007", "unstructured": "Alex KD, Pehek EA (2007). Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113: 296\u2013320.", "journal-title": "Pharmacol Ther"}, {"key": "BFnpp2008176_CR3", "first-page": "224", "volume": "22", "author": "F Artigas", "year": "2001", "unstructured": "Artigas F, Celada P, Laruelle M, Adell A (2001). How does pindolol improve antidepressant action? TIPS 22: 224\u2013228.", "journal-title": "TIPS"}, {"key": "BFnpp2008176_CR4", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1016/j.bbr.2006.12.015", "volume": "182", "author": "GS Bassi", "year": "2007", "unstructured": "Bassi GS, Nobre MJ, Carvalho MC, Brand\u00e3o ML (2007). Substance P injected into the dorsal periaqueductal gray causes anxiogenic effects similar to the long-term isolation as assessed by ultrasound vocalizations measurements. Behav Brain Res 182: 301\u2013307.", "journal-title": "Behav Brain Res"}, {"key": "BFnpp2008176_CR5", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1002/syn.10021", "volume": "43", "author": "L Bert", "year": "2002", "unstructured": "Bert L, Rodier D, Bougault I, Allouard N, Le-Fur G, Soubri\u00e9 P et al (2002). Permissive role of neurokinin NK3 receptors in NK1 receptor-mediated activation of the locus coeruleus revealed by SR 142801. Synapse 43: 62\u201369.", "journal-title": "Synapse"}, {"key": "BFnpp2008176_CR6", "first-page": "208", "volume": "29", "author": "P Blier", "year": "2004", "unstructured": "Blier P, Gobbi G, Haddjeri N, Santarelli L, Mathew G, Hen R (2004). Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. J Psychiatry Neurosci 29: 208\u2013218.", "journal-title": "J Psychiatry Neurosci"}, {"key": "BFnpp2008176_CR7", "doi-asserted-by": "crossref", "first-page": "729", "DOI": "10.1016/j.euroneuro.2008.06.002", "volume": "18", "author": "M Brocco", "year": "2008", "unstructured": "Brocco M, Dekeyne A, Mannoury la Cour C, Touzard M, Girardon S, Veiga S et al (2008). Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents. Eur Neuropsychopharmacol 18: 729\u2013750.", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "BFnpp2008176_CR8", "doi-asserted-by": "crossref", "first-page": "559", "DOI": "10.1097/01.fbp.0000236267.41806.5b", "volume": "17", "author": "M Brocco", "year": "2006", "unstructured": "Brocco M, Dekeyne A, Papp M, Millan MJ (2006). Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors. Behav Pharmacol 17: 559\u2013572.", "journal-title": "Behav Pharmacol"}, {"key": "BFnpp2008176_CR9", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1016/S0091-3057(01)00701-8", "volume": "71", "author": "M Brocco", "year": "2002", "unstructured": "Brocco M, Dekeyne A, Veiga S, Girardon S, Millan MJ (2002). Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake a pharmacological characterization of diverse classes of antidepressant agents. Pharmacol Biochem Behav 71: 667\u2013680.", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BFnpp2008176_CR10", "doi-asserted-by": "crossref", "first-page": "1111", "DOI": "10.1016/j.biopsych.2006.11.023", "volume": "62", "author": "NS Burghardt", "year": "2007", "unstructured": "Burghardt NS, Bush DEA, McEwen BS, LeDoux JE (2007). Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT2C receptor antagonist. Biol Psychiatry 62: 1111\u20131118.", "journal-title": "Biol Psychiatry"}, {"key": "BFnpp2008176_CR11", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0006-8993(03)03384-5", "volume": "993", "author": "BM Campbell", "year": "2003", "unstructured": "Campbell BM, Merchant KM (2003). Serotonin2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment. Brain Res 993: 1\u20139.", "journal-title": "Brain Res"}, {"key": "BFnpp2008176_CR12", "doi-asserted-by": "crossref", "first-page": "9917", "DOI": "10.1523/JNEUROSCI.21-24-09917.2001", "volume": "21", "author": "P Celada", "year": "2001", "unstructured": "Celada P, Puig MV, Casanovas JM, Guillazo G, Artigas F (2001). Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. J Neurosci 21: 9917\u20139929.", "journal-title": "J Neurosci"}, {"key": "BFnpp2008176_CR13", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1016/j.bbr.2006.05.011", "volume": "172", "author": "F Chenu", "year": "2006", "unstructured": "Chenu F, Guiard BP, Bourin M, Gardier AM (2006). Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behav Brain Res 172: 256\u2013263.", "journal-title": "Behav Brain Res"}, {"key": "BFnpp2008176_CR14", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1002/cne.10228", "volume": "447", "author": "KG Commons", "year": "2002", "unstructured": "Commons KG, Valentino RJ (2002). Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus. J Comp Neurol 447: 82\u201397.", "journal-title": "J Comp Neurol"}, {"key": "BFnpp2008176_CR15", "doi-asserted-by": "crossref", "first-page": "7730", "DOI": "10.1523/JNEUROSCI.22-17-07730.2002", "volume": "22", "author": "RK Conley", "year": "2002", "unstructured": "Conley RK, Cumberbatch MJ, Mason GS, Williamson DJ, Harrison T, Locker K et al (2002). Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity. J Neurosci 22: 7730\u20137736.", "journal-title": "J Neurosci"}, {"key": "BFnpp2008176_CR16", "doi-asserted-by": "crossref", "first-page": "1550", "DOI": "10.1038/sj.npp.1301287", "volume": "31", "author": "TI Cremers", "year": "2007", "unstructured": "Cremers TI, Rea K, Bosker FJ, Wikstr\u00f6m HV, Hogg S, Mork A et al (2007). Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Neuropsychopharmacology 31: 1550\u20131557.", "journal-title": "Neuropsychopharmacology"}, {"key": "BFnpp2008176_CR17", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1517/13543784.15.5.479", "volume": "15", "author": "B Czeh", "year": "2006", "unstructured": "Czeh B, Fuchs E, Simon M (2006). NK1 receptor antagonists under investigation for the treatment of affective disorders. Expert Opin Investig Drugs 15: 479\u2013486.", "journal-title": "Expert Opin Investig Drugs"}, {"key": "BFnpp2008176_CR18", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/j.ejphar.2004.11.024", "volume": "507", "author": "LJ Dableh", "year": "2005", "unstructured": "Dableh LJ, Yashpal K, Rochford J, Henry JL (2005). Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat. Eur J Pharmacol 507: 99\u2013105.", "journal-title": "Eur J Pharmacol"}, {"key": "BFnpp2008176_CR19", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/0014-2999(93)90530-U", "volume": "249", "author": "J De Vry", "year": "1993", "unstructured": "De Vry J, Benz U, Schreiber R, Traber J (1993). Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs. Eur J Pharmacol 249: 331\u2013339.", "journal-title": "Eur J Pharmacol"}, {"key": "BFnpp2008176_CR20", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1016/S0028-3908(99)00268-3", "volume": "39", "author": "A Dekeyne", "year": "2000", "unstructured": "Dekeyne A, Denorme B, Monneyron S, Millan MJ (2000). Citalopram reduces social interaction in rats by activation of serotonin (5-HT)2C receptors. Neuropharmacology 39: 114\u20131117.", "journal-title": "Neuropharmacology"}, {"key": "BFnpp2008176_CR21", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1016/S0163-7258(96)00092-7", "volume": "71", "author": "WC Duncan", "year": "1996", "unstructured": "Duncan WC (1996). Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther 71: 253\u2013312.", "journal-title": "Pharmacol Ther"}, {"key": "BFnpp2008176_CR22", "doi-asserted-by": "crossref", "first-page": "4280", "DOI": "10.1073/pnas.0400794101", "volume": "101", "author": "K Ebner", "year": "2004", "unstructured": "Ebner K, Rupniak NM, Saria A, Singewald N (2004). Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci USA 101: 4280\u20134285.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFnpp2008176_CR23", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1007/s00210-007-0185-3", "volume": "376", "author": "K Ebner", "year": "2007", "unstructured": "Ebner K, Singewald GM (2007). Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol 376: 73\u201382.", "journal-title": "Naunyn Schmiedebergs Arch Pharmacol"}, {"key": "BFnpp2008176_CR24", "doi-asserted-by": "crossref", "first-page": "1929", "DOI": "10.1038/sj.npp.1301594", "volume": "33", "author": "K Ebner", "year": "2008", "unstructured": "Ebner K, Singewald GM, Whittle N, Ferraguti F, Singewald N (2008). Neurokinin1 receptor antagonism promotes active stress coping via enhanced septal 5-HT1A transmission. Neuropsychopharmacology 33: 1929\u20131941.", "journal-title": "Neuropsychopharmacology"}, {"key": "BFnpp2008176_CR25", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1016/j.bcp.2006.09.030", "volume": "73", "author": "S Engberg", "year": "2007", "unstructured": "Engberg S, Ahlstedt I, Leffler A, Lindstr\u00f6m E, Kristensson E, Svensson A et al (2007). Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors. Biochem Pharmacol 73: 259\u2013269.", "journal-title": "Biochem Pharmacol"}, {"key": "BFnpp2008176_CR26", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1016/S0091-3057(97)90002-2", "volume": "58", "author": "SE File", "year": "1997", "unstructured": "File SE (1997). Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test. Pharmacol Biochem Behav 58: 747\u2013752.", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BFnpp2008176_CR27", "doi-asserted-by": "crossref", "first-page": "8188", "DOI": "10.1523/JNEUROSCI.21-20-08188.2001", "volume": "15", "author": "N Froger", "year": "2001", "unstructured": "Froger N, Gardier AM, Moratalla R, Alberti I, Lena I, Boni C et al (2001). 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin1) receptor knock-out mice mimic antidepressant-induced desensitization. Neuroscience 15: 8188\u20138197.", "journal-title": "Neuroscience"}, {"key": "BFnpp2008176_CR28", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1016/j.biopsych.2005.03.029", "volume": "58", "author": "T Furmark", "year": "2005", "unstructured": "Furmark T, Appel L, Michelg\u00e5rd A, Wahlstedt K, Ahs F, Zancan S et al (2005). Cerebral flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram or placebo. Biol Psychiatry 58: 132\u2013142.", "journal-title": "Biol Psychiatry"}, {"key": "BFnpp2008176_CR29", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1016/j.ejphar.2005.10.012", "volume": "527", "author": "RI Gannon", "year": "2005", "unstructured": "Gannon RI, Millan MJ (2005). The selective neurokinin1 (NK1) receptor antagonist, GR 205171, stereospecifically inhibits light-induced phase shifts of hamster circadian activity rhythms. Eur J Pharmacol 527: 86\u201393.", "journal-title": "Eur J Pharmacol"}, {"key": "BFnpp2008176_CR30", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1007/s00213-007-0903-z", "volume": "195", "author": "RL Gannon", "year": "2007", "unstructured": "Gannon RL, Millan MJ (2007). Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms. Psychopharmacology 195: 325\u2013332.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp2008176_CR31", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1016/0167-0115(96)00071-7", "volume": "65", "author": "CJ Gardner", "year": "1996", "unstructured": "Gardner CJ, Armour DR, Beattie DT, Gale JD, Hawcock AB, Kilpatrick GJ et al (1996). GR205171: a novel antagonist with high affinity for the tachykinin NK1receptor, and potent broad-spectrum anti-emetic activity. Regul Pept 65: 45\u201353.", "journal-title": "Regul Pept"}, {"key": "BFnpp2008176_CR32", "doi-asserted-by": "crossref", "first-page": "10208", "DOI": "10.1073/pnas.88.22.10208", "volume": "88", "author": "C Garret", "year": "1991", "unstructured": "Garret C, Carruette A, Fardin V, Moussoui S, Peyronel JF, Blanchard JC et al (1991). Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci USA 88: 10208\u201310212.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFnpp2008176_CR33", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1016/j.ddstr.2006.11.010", "volume": "4", "author": "CPG Gerald", "year": "2006", "unstructured": "Gerald CPG, Antonijevic IA, Branchek TA (2006). Novel mechanisms to treat depression and anxiety. Will neuropeptide antagonists succeed? Drug Discov Today Ther Strateg 4: 467\u2013473.", "journal-title": "Drug Discov Today Ther Strateg"}, {"key": "BFnpp2008176_CR34", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1016/j.euroneuro.2006.07.004", "volume": "17", "author": "G Gobbi", "year": "2007", "unstructured": "Gobbi G, Cassano T, Radja F, Morgese MG, Cuomo V, Santarelli L et al (2007). Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. Eur Neuropsychopharmacol 17: 328\u2013338.", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "BFnpp2008176_CR35", "first-page": "1032", "volume": "273", "author": "A Gobert", "year": "1995", "unstructured": "Gobert A, Lejeune F, Rivet J-M, Audinot V, Newman-Tancredi A, Millan MJ (1995). Modulation of the activity of central serotoninergic neurones by novel serotonin1A receptor agonists and antagonists: A comparison to adrenergic and dopaminergic neurones in individual rats. J Pharmacol Exp Ther 273: 1032\u20131046.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BFnpp2008176_CR36", "doi-asserted-by": "crossref", "first-page": "1251", "DOI": "10.1016/S0306-4522(99)00211-0", "volume": "93", "author": "A Gobert", "year": "1999", "unstructured": "Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ (1999). Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions. Neuroscience 93: 1251\u20131262.", "journal-title": "Neuroscience"}, {"key": "BFnpp2008176_CR37", "doi-asserted-by": "crossref", "first-page": "1159", "DOI": "10.1046/j.1471-4159.1997.68031159.x", "volume": "68", "author": "A Gobert", "year": "1997", "unstructured": "Gobert A, Rivet J-M, Cistarelli L, Millan MJ (1997). Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely-moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY100\u2009635 and GR127\u2009935. J Neurochem 68: 1159\u20131163.", "journal-title": "J Neurochem"}, {"key": "BFnpp2008176_CR38", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1038/sj.bjp.0706697", "volume": "148", "author": "C Griffante", "year": "2006", "unstructured": "Griffante C, Carletti R, Andreetta F, Corsi M (2006). [3H]GR205171 displays similar NK1receptor binding profile in gerbil and human brain. Br J Pharmacol 148: 39\u201345.", "journal-title": "Br J Pharmacol"}, {"key": "BFnpp2008176_CR39", "doi-asserted-by": "crossref", "first-page": "1713", "DOI": "10.1111/j.1471-4159.2005.03488.x", "volume": "95", "author": "BP Guiard", "year": "2005", "unstructured": "Guiard BP, Froger N, Hamon M, Gardier AM, Lanfumey L (2005). Sustained pharmacological blockage of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT1A autoreceptors in mice. J Neurochem 95: 1713\u20131723.", "journal-title": "J Neurochem"}, {"key": "BFnpp2008176_CR40", "doi-asserted-by": "crossref", "first-page": "1411", "DOI": "10.1124/mol.107.040113", "volume": "72", "author": "BP Guiard", "year": "2007", "unstructured": "Guiard BP, Guilloux JP, Reperant C, Hunt SP, Toth M, Gardier AM (2007). Substance P neurokinin1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex. Mol Pharmacol 72: 1411\u20131418.", "journal-title": "Mol Pharmacol"}, {"key": "BFnpp2008176_CR41", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1046/j.1471-4159.2003.02304.x", "volume": "89", "author": "BP Guiard", "year": "2004", "unstructured": "Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, de Felipe C et al (2004). Blockade of substance P (neurokinin1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice. J Neurochem 89: 54\u201363.", "journal-title": "J Neurochem"}, {"key": "BFnpp2008176_CR42", "doi-asserted-by": "crossref", "first-page": "2162", "DOI": "10.1038/sj.npp.1301019", "volume": "31", "author": "JP Guilloux", "year": "2006", "unstructured": "Guilloux JP, David DJ, Guiard BP, Chenu F, Rep\u00e9rant C, Toth M et al (2006). Blockade of 5-HT1A receptors by (+/\u2212)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioural approaches in 5-HT1A receptor knockout mice. Neuropsychopharmacology 31: 2162\u20132172.", "journal-title": "Neuropsychopharmacology"}, {"key": "BFnpp2008176_CR43", "doi-asserted-by": "crossref", "first-page": "1323", "DOI": "10.1097/00001756-200004270-00035", "volume": "11", "author": "N Haddjeri", "year": "2000", "unstructured": "Haddjeri N, Blier P (2000). Effect of neurokinin-1 receptor antagonists on the function of 5-HT and noradrenaline neurons. Neuroreport 11: 1323\u20131327.", "journal-title": "Neuroreport"}, {"key": "BFnpp2008176_CR44", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1016/S0006-3223(01)01162-3", "volume": "50", "author": "N Haddjeri", "year": "2001", "unstructured": "Haddjeri N, Blier P (2001). Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission. Biol Psychiatry 50: 191\u2013199.", "journal-title": "Biol Psychiatry"}, {"key": "BFnpp2008176_CR45", "first-page": "3397", "volume": "11", "author": "N Haddjeri", "year": "2000", "unstructured": "Haddjeri N, Lucas G, Blier P (2000). Role of cholinergic and GABAergic systems in the feedback inhibition of dorsal raphe 5-HT neurons. Neuroreport 11: 3397\u20133401.", "journal-title": "Neuroreport"}, {"key": "BFnpp2008176_CR46", "doi-asserted-by": "crossref", "first-page": "706", "DOI": "10.1016/j.neuropharm.2004.12.016", "volume": "48", "author": "L Herpfer", "year": "2005", "unstructured": "Herpfer L, Hunt SP, Stanford SC (2005). A comparison of neurokinin1 receptor knock-out (NK1\u2212/\u2212) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects. Neuropharmacology 48: 706\u2013719.", "journal-title": "Neuropharmacology"}, {"key": "BFnpp2008176_CR47", "doi-asserted-by": "crossref", "first-page": "580", "DOI": "10.1016/j.tips.2003.09.011", "volume": "24", "author": "A Holmes", "year": "2003", "unstructured": "Holmes A, Heilig M, Rupniak NMJ, Steckler T, Griebel G (2003). Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24: 580\u2013588.", "journal-title": "Trends Pharmacol Sci"}, {"key": "BFnpp2008176_CR48", "doi-asserted-by": "crossref", "first-page": "1523", "DOI": "10.1016/j.neuroscience.2006.11.004", "volume": "144", "author": "RW Invernizzi", "year": "2007", "unstructured": "Invernizzi RW, Pierucci M, Calcagno E, Di Giovanni G, Di Matteo V, Benigno A et al (2007). Selective activation of 5-HT2C receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study. Neuroscience 144: 1523\u20131535.", "journal-title": "Neuroscience"}, {"key": "BFnpp2008176_CR49", "doi-asserted-by": "crossref", "first-page": "1640", "DOI": "10.1126/science.281.5383.1640", "volume": "281", "author": "MS Kramer", "year": "1998", "unstructured": "Kramer MS, Cutler NR, Keighner J, Shrivastava R, Carman J, Sramek JJ et al (1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640\u20131645.", "journal-title": "Science"}, {"key": "BFnpp2008176_CR50", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.1038/sj.npp.1300260", "volume": "29", "author": "MS Kramer", "year": "2004", "unstructured": "Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D et al (2004). Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology 29: 385\u2013392.", "journal-title": "Neuropsychopharmacology"}, {"key": "BFnpp2008176_CR51", "doi-asserted-by": "crossref", "first-page": "2947", "DOI": "10.1111/j.1460-9568.2006.04833.x", "volume": "23", "author": "B Lacoste", "year": "2006", "unstructured": "Lacoste B, Riad M, Descarries L (2006). Immunocytochemical evidence for the existence of substance P receptor (NK1) in serotonin neurons of rat and mouse dorsal raphe nucleus. Eur J Neurosci 23: 2947\u20132958.", "journal-title": "Eur J Neurosci"}, {"key": "BFnpp2008176_CR52", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1016/S0304-3940(01)02543-5", "volume": "323", "author": "L L\u00e9ger", "year": "2002", "unstructured": "L\u00e9ger L, Gay N, Cespuglio R (2002). Neurokinin NK1- and NK3-immunoreactive neurons in serotonergic cell groups in the rat brain. Neurosci Lett 323: 146\u2013150.", "journal-title": "Neurosci Lett"}, {"key": "BFnpp2008176_CR53", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/S0006-8993(00)03290-X", "volume": "893", "author": "R Legutko", "year": "2001", "unstructured": "Legutko R, Gannon RL (2001). Serotonin transporter localization in the hamster suprachiasmatic nucleus. Brain Res 893: 77\u201383.", "journal-title": "Brain Res"}, {"key": "BFnpp2008176_CR54", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1016/S0006-8993(02)02476-9", "volume": "935", "author": "F Lejeune", "year": "2002", "unstructured": "Lejeune F, Gobert A, Millan MJ (2002). The selective neurokinin (NK)1 antagonist, GR205171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study. Brain Res 935: 134\u2013139.", "journal-title": "Brain Res"}, {"key": "BFnpp2008176_CR55", "doi-asserted-by": "crossref", "first-page": "3265", "DOI": "10.1046/j.1460-9568.2000.00222.x", "volume": "12", "author": "F Lejeune", "year": "2000", "unstructured": "Lejeune F, Millan MJ (2000). Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5-HT1A receptors. Eur J Neurosci 12: 3265\u20133275.", "journal-title": "Eur J Neurosci"}, {"key": "BFnpp2008176_CR56", "first-page": "1241", "volume": "280", "author": "F Lejeune", "year": "1997", "unstructured": "Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ (1997). Interaction of (+)- and (\u2212)-8- and 7-hydroxy-2-(di-n-propylamino)tetraline at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotonergic and dopaminergic neurones in rats. J Pharmacol Exp Ther 280: 1241\u20131249.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BFnpp2008176_CR57", "doi-asserted-by": "crossref", "first-page": "1309", "DOI": "10.1016/j.neuroscience.2005.07.025", "volume": "135", "author": "A Lessard", "year": "2005", "unstructured": "Lessard A, Pickel VM (2005). Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area. Neuroscience 135: 1309\u20131323.", "journal-title": "Neuroscience"}, {"key": "BFnpp2008176_CR58", "doi-asserted-by": "crossref", "first-page": "641", "DOI": "10.1016/j.euroneuro.2005.04.013", "volume": "15", "author": "K Lieb", "year": "2005", "unstructured": "Lieb K, Fiebich BL, Herpfer I, Mantovani M, L\u00f6ffler M, Feuerstein TJ (2005). No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes. Eur Neuropsychopharmacol 15: 641\u2013646.", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "BFnpp2008176_CR59", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1016/S0893-133X(02)00305-6", "volume": "27", "author": "R Liu", "year": "2002", "unstructured": "Liu R, Ding Y, Aghajanian GK (2002). Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus. Neuropsychopharmacology 27: 329\u2013340.", "journal-title": "Neuropsychopharmacology"}, {"key": "BFnpp2008176_CR60", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1016/0149-7634(94)90039-6", "volume": "18", "author": "I Lucki", "year": "1994", "unstructured": "Lucki I, Singh A, Kreiss DS (1994). Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 18: 85\u201395.", "journal-title": "Neurosci Biobehav Rev"}, {"key": "BFnpp2008176_CR61", "doi-asserted-by": "crossref", "first-page": "1809", "DOI": "10.1097/00001756-200210070-00024", "volume": "13", "author": "Q-P Ma", "year": "2002", "unstructured": "Ma Q-P, Bleasdale C (2002). Modulation of brain stem monoamines and gamma aminobutyric acid by NK1 receptors in rats. Neuroreport 13: 1809\u20131813.", "journal-title": "Neuroreport"}, {"key": "BFnpp2008176_CR62", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1016/S0306-4522(01)00467-5", "volume": "109", "author": "KA Maubach", "year": "2002", "unstructured": "Maubach KA, Martin K, Chicchi G, Harrison T, Wheeldon A, Swain CJ et al (2002). Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus. Neuroscience 109: 609\u2013617.", "journal-title": "Neuroscience"}, {"key": "BFnpp2008176_CR63", "doi-asserted-by": "crossref", "first-page": "1002", "DOI": "10.1016/j.biopsych.2006.07.003", "volume": "61", "author": "A Michelgard", "year": "2007", "unstructured": "Michelgard A, Appel L, Pissiota A, Frans O, Langstr\u00f6m B, Bergstr\u00f6m M et al (2007). Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system. Biol Psychiatry 61: 1002\u20131006.", "journal-title": "Biol Psychiatry"}, {"key": "BFnpp2008176_CR64", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/S0301-0082(03)00087-X", "volume": "70", "author": "MJ Millan", "year": "2003", "unstructured": "Millan MJ (2003). The neurobiology and control anxious states. Prog Neurobiol 70: 83\u2013244.", "journal-title": "Prog Neurobiol"}, {"key": "BFnpp2008176_CR65", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1016/j.ejphar.2004.07.038", "volume": "500", "author": "MJ Millan", "year": "2004", "unstructured": "Millan MJ (2004). The role of monoamines in the action of established and \u2018novel\u2019 antidepressant agents: a critical review. Eur J Pharmacol 500: 371\u2013384.", "journal-title": "Eur J Pharmacol"}, {"key": "BFnpp2008176_CR66", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/j.pharmthera.2005.11.006", "volume": "110", "author": "MJ Millan", "year": "2006", "unstructured": "Millan MJ (2006). Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110: 135\u2013370.", "journal-title": "Pharmacol Ther"}, {"key": "BFnpp2008176_CR67", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1016/S0893-133X(01)00244-5", "volume": "25", "author": "MJ Millan", "year": "2001", "unstructured": "Millan MJ, Brocco M, Gobert A, Dorey G, Casara P, Dekeyne A (2001a). Anxiolytic properties of the selective, non-peptidergic CRF1 antagonists, CP154\u2009526 and DMP695: a comparison to other classes of anxiolytic agent. Neuropsychopharmacology 25: 585\u2013600.", "journal-title": "Neuropsychopharmacology"}, {"key": "BFnpp2008176_CR68", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1016/S0028-3908(99)00012-X", "volume": "38", "author": "MJ Millan", "year": "1999", "unstructured": "Millan MJ, Gobert A (1999). (\u2212)-Pindolol increases dialysate concentrations of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely-moving rats. Neuropharmacology 38: 909\u2013912.", "journal-title": "Neuropharmacology"}, {"key": "BFnpp2008176_CR69", "first-page": "148", "volume": "282", "author": "MJ Millan", "year": "1997", "unstructured": "Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B et al (1997a). S15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. J Pharmacol Exp Ther 282: 148\u2013161.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BFnpp2008176_CR70", "doi-asserted-by": "crossref", "first-page": "1949", "DOI": "10.1046/j.1471-4159.2001.00211.x", "volume": "76", "author": "MJ Millan", "year": "2001", "unstructured": "Millan MJ, Lejeune F, De Nanteuil G, Gobert A (2001b). Selective blockade of neurokinin (NK)1 receptors facilitates the activity of adrenergic pathways projecting to the frontal cortex and dorsal hippocampus in the rat. J Neurochem 76: 1949\u20131954.", "journal-title": "J Neurochem"}, {"key": "BFnpp2008176_CR71", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1177/026988110001400202", "volume": "14", "author": "MJ Millan", "year": "2000", "unstructured": "Millan MJ, Lejeune F, Gobert A (2000). Reciprocal autoreceptor and heteroceptor control of serotonergic, dopaminergic and adrenergic transmission in frontal cortex: a review, and relevance to the actions of antidepressant agents. J Psychopharmacol 14: 114\u2013138.", "journal-title": "J Psychopharmacol"}, {"key": "BFnpp2008176_CR72", "first-page": "132", "volume": "282", "author": "MJ Millan", "year": "1997", "unstructured": "Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V et al (1997b). S15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h\u03b12A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. J Pharmacol Exp Ther 282: 132\u2013147.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BFnpp2008176_CR73", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1007/s002130050106", "volume": "128", "author": "HE Molewijk", "year": "1996", "unstructured": "Molewijk HE, Hartog K, van der Poel AM, Mos J, Olivier B (1996). Reduction of guinea pig pup isolation calls by anxiolytic and antidepressant drugs. Psychopharmacology 128: 31\u201338.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp2008176_CR74", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1017/S1461145704004080", "volume": "7", "author": "DA Morilak", "year": "2004", "unstructured": "Morilak DA, Frazer A (2004). Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol 7: 193\u2013218.", "journal-title": "Int J Neuropsychopharmacol"}, {"key": "BFnpp2008176_CR75", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1016/S0893-133X(97)00169-3", "volume": "18", "author": "A Newman-Tancredi", "year": "1998", "unstructured": "Newman-Tancredi A, Chaput C, Gavaudan S, Verri\u00e8le L, Millan MJ (1998). Agonist and antagonist action of (\u2212)-pindolol at recombinant, human 5-HT1A receptors. Neuropsychopharmacology 18: 395\u2013398.", "journal-title": "Neuropsychopharmacology"}, {"key": "BFnpp2008176_CR76", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1007/s002130050663", "volume": "138", "author": "JP Redrobe", "year": "1998", "unstructured": "Redrobe JP, Bourin M (1998). Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test. Psychopharmacology 138: 198\u2013206.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp2008176_CR77", "doi-asserted-by": "crossref", "first-page": "961", "DOI": "10.1002/jnr.20997", "volume": "84", "author": "G Renoldi", "year": "2006", "unstructured": "Renoldi G, Invernizzi RW (2006). Blockade of tachikinin NK1 receptors attenuates stress-induced rise of extracellular noradrenaline and dopamine in the rat and gerbil medial prefrontal. J Neurosci Res 84: 961\u2013968.", "journal-title": "J Neurosci Res"}, {"key": "BFnpp2008176_CR78", "doi-asserted-by": "crossref", "first-page": "1413", "DOI": "10.1016/S0028-3908(00)00052-6", "volume": "39", "author": "NM Rupniak", "year": "2000", "unstructured": "Rupniak NM, Carlson EC, Harrison T, Oates B, Seward E, Owen S et al (2000). Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology 39: 1413\u20131421.", "journal-title": "Neuropharmacology"}, {"key": "BFnpp2008176_CR79", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.1097/00008877-200111000-00011", "volume": "12", "author": "NM Rupniak", "year": "2001", "unstructured": "Rupniak NM, Carlson EJ, Webb JK, Harrison T, Porsolt RD, Roux S et al (2001). Comparison of the phenotype of NK1R\u2212/\u2212 mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs. Behav Pharmacol 12: 497\u2013508.", "journal-title": "Behav Pharmacol"}, {"key": "BFnpp2008176_CR80", "doi-asserted-by": "crossref", "first-page": "516", "DOI": "10.1016/S0028-3908(03)00023-6", "volume": "44", "author": "NMJ Rupniak", "year": "2003", "unstructured": "Rupniak NMJ, Webb JK, Fisher A, Smith D, Boyce S (2003). The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils. Neuropharmacology 44: 516\u2013523.", "journal-title": "Neuropharmacology"}, {"key": "BFnpp2008176_CR81", "doi-asserted-by": "crossref", "first-page": "3195", "DOI": "10.1016/S0960-894X(02)00563-2", "volume": "12", "author": "T Ryckmans", "year": "2002", "unstructured": "Ryckmans T, Berton O, Grim\u00e9e R, Kogej T, Lamberty Y, Pasau P et al (2002). Dual NK1 antagonists-serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives. Bioorg Med Chem Lett 12: 3195\u20133198.", "journal-title": "Bioorg Med Chem Lett"}, {"key": "BFnpp2008176_CR82", "doi-asserted-by": "crossref", "first-page": "761", "DOI": "10.1016/S0306-4522(02)00748-0", "volume": "116", "author": "M Saffroy", "year": "2003", "unstructured": "Saffroy M, Torrens Y, Glowinski J, Beaujouan J-C (2003). Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites. Neuroscience 116: 761\u2013773.", "journal-title": "Neuroscience"}, {"key": "BFnpp2008176_CR83", "doi-asserted-by": "crossref", "first-page": "282", "DOI": "10.1007/s00213-005-0247-5", "volume": "185", "author": "P Salchner", "year": "2006", "unstructured": "Salchner P, Singewald N (2006). 5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats. Psychopharmacology 185: 282\u2013288.", "journal-title": "Psychopharmacology"}, {"key": "BFnpp2008176_CR84", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1016/S0014-2999(03)01277-9", "volume": "463", "author": "C S\u00e1nchez", "year": "2003", "unstructured": "S\u00e1nchez C (2003). Stress-induced vocalization in adult animals. A valid model of anxiety? Eur J Pharmacol 463: 133\u2013143.", "journal-title": "Eur J Pharmacol"}, {"key": "BFnpp2008176_CR85", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1007/s002130050181", "volume": "129", "author": "C Sanchez", "year": "1997", "unstructured": "Sanchez C, Meier E (1997). Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmaocology 129: 197\u2013205.", "journal-title": "Psychopharmaocology"}, {"key": "BFnpp2008176_CR86", "doi-asserted-by": "crossref", "first-page": "1912", "DOI": "10.1073/pnas.98.4.1912", "volume": "98", "author": "L Santarelli", "year": "2001", "unstructured": "Santarelli L, Gobbi G, Debs PC, Sibille EL, Blier P, Hen R et al (2001). Genetic and pharmacological distribution of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98: 1912\u20131917.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFnpp2008176_CR87", "doi-asserted-by": "crossref", "first-page": "1177", "DOI": "10.1016/j.neuropharm.2004.02.013", "volume": "46", "author": "SB Sartori", "year": "2004", "unstructured": "Sartori SB, Burnet PWJ, Sharp T, Singewald N (2004). Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brain. Neuropharmacology 46: 1177\u20131183.", "journal-title": "Neuropharmacology"}, {"key": "BFnpp2008176_CR88", "first-page": "629", "volume": "28", "author": "T Sharp", "year": "2007", "unstructured": "Sharp T, Boothman L, Raley J, Qu\u00e9r\u00e9e P (2007). Important messages in the \u2018post\u2019: recent discoveries in 5-HT neurone feedback control. TiNS 28: 629\u2013636.", "journal-title": "TiNS"}, {"key": "BFnpp2008176_CR89", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1016/j.brainresrev.2004.04.009", "volume": "46", "author": "TP Sheehan", "year": "2004", "unstructured": "Sheehan TP, Chambers RA, Russell DS (2004). Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Rev 46: 71\u2013117.", "journal-title": "Brain Res Rev"}, {"key": "BFnpp2008176_CR90", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/S0006-8993(96)00812-8", "volume": "739", "author": "Y Shirayama", "year": "1996", "unstructured": "Shirayama Y, Mitsushio H, Takashima M, Ichikawa H, Takahashi K (1996). Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat. Brain Res 739: 70\u201378.", "journal-title": "Brain Res"}, {"key": "BFnpp2008176_CR91", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1002/1096-9861(20010212)430:3<283::AID-CNE1031>3.0.CO;2-V", "volume": "430", "author": "RS Sloviter", "year": "2001", "unstructured": "Sloviter RS, Ali-Akbarian L, Horvath KD, Menkens KA (2001). Substance P receptor expression by inhibitory interneurons of the rat hippocampus: enhanced detection using improved immunocytochemical methods for the preservation and colocalization of GABA and other neuronal markers. J Comp Neurol 430: 283\u2013305.", "journal-title": "J Comp Neurol"}, {"key": "BFnpp2008176_CR92", "doi-asserted-by": "crossref", "first-page": "967", "DOI": "10.1038/nrd1905", "volume": "4", "author": "W Spooren", "year": "2005", "unstructured": "Spooren W, Riemer C, Meltzer H (2005). NK3 receptor antagonists: the next generation of antipsychotics? Nat Rev Drug Discov 4: 967\u2013975.", "journal-title": "Nat Rev Drug Discov"}, {"key": "BFnpp2008176_CR93", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1016/S0306-4522(02)00412-8", "volume": "115", "author": "AE Stacey", "year": "2002", "unstructured": "Stacey AE, Woodhall GL, Jones RSG (2002). Activation of neurokinin1 receptors GABA release at synapses in rat entorhinal cortex. Neuroscience 115: 575\u2013586.", "journal-title": "Neuroscience"}, {"key": "BFnpp2008176_CR94", "first-page": "449", "volume": "299", "author": "R Steinberg", "year": "2001", "unstructured": "Steinberg R, Alonso R, Griebel G, Bert L, Jung M, Oury-Donat F et al (2001). Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotrophin-releasing factor function. J Pharmacol Exp Ther 299: 449\u2013458.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BFnpp2008176_CR95", "doi-asserted-by": "crossref", "first-page": "1205", "DOI": "10.1016/0306-4522(95)00315-A", "volume": "69", "author": "Z Szeidemann", "year": "1995", "unstructured": "Szeidemann Z, Jakab RL, Shanabrough M, Leranth C (1995). Extrinsic and intrinsic substance P innervation of the rat lateral septal area calbindin cells. Neuroscience 69: 1205\u20131221.", "journal-title": "Neuroscience"}, {"key": "BFnpp2008176_CR96", "doi-asserted-by": "crossref", "first-page": "7155", "DOI": "10.1523/JNEUROSCI.23-18-07155.2003", "volume": "23", "author": "RJ Valentino", "year": "2003", "unstructured": "Valentino RJ, Bey V, Pernar L, Commons KG (2003). Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity. J Neurosci 23: 7155\u20137159.", "journal-title": "J Neurosci"}, {"key": "BFnpp2008176_CR97", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1016/S0893-133X(02)00313-5", "volume": "27", "author": "GB Varty", "year": "2002", "unstructured": "Varty GB, Cohen-Williams ME, Morgan CA, Pylak U, Duffy RA, Lachowicz JE et al (2002). The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology 27: 371\u2013379.", "journal-title": "Neuropsychopharmacology"}], "container-title": ["Neuropsychopharmacology"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/npp2008176.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/npp2008176", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/npp2008176.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 24]], "date-time": "2019-04-24T11:19:28Z", "timestamp": 1556104768000}, "score": 40.44815, "issued": {"date-parts": [[2008, 10, 1]]}, "references-count": 97, "journal-issue": {"published-print": {"date-parts": [[2009, 3]]}, "issue": "4"}, "alternative-id": ["BFnpp2008176"], "URL": "http://dx.doi.org/10.1038/npp.2008.176", "relation": {"cites": []}, "ISSN": ["0893-133X", "1740-634X"], "issn-type": [{"value": "0893-133X", "type": "print"}, {"value": "1740-634X", "type": "electronic"}], "subject": ["Pharmacology", "Psychiatry and Mental health"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:33:52Z", "timestamp": 1574116432783}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 10, 1]], "date-time": "2003-10-01T00:00:00Z", "timestamp": 1064966400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2003, 10]]}, "DOI": "10.1016/s0924-977x(03)91930-4", "type": "journal-article", "created": {"date-parts": [[2004, 3, 31]], "date-time": "2004-03-31T11:53:20Z", "timestamp": 1080734000000}, "page": "S268", "source": "Crossref", "is-referenced-by-count": 0, "title": ["P.1.220 Influence of \u03b12-adrenoceptor blockade upon the antidepressant profiles of monoamine reuptake inhibitors: A combined neurochemical and behavioural analysis"], "prefix": "10.1016", "volume": "13", "author": [{"given": "M.J.", "family": "Brocco", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Gobert", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Dekeyne", "sequence": "additional", "affiliation": []}, {"given": "M.J.", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X03919304?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X03919304?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 14]], "date-time": "2019-02-14T09:26:26Z", "timestamp": 1550136386000}, "score": 39.311623, "issued": {"date-parts": [[2003, 10]]}, "references-count": 0, "alternative-id": ["S0924977X03919304"], "URL": "http://dx.doi.org/10.1016/s0924-977x(03)91930-4", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T08:27:25Z", "timestamp": 1574238445309}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "SUPPLEMENT 1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Pharmacology"], "published-print": {"date-parts": [[1999, 8]]}, "DOI": "10.1097/00008877-199908001-00058", "type": "journal-article", "created": {"date-parts": [[2006, 10, 20]], "date-time": "2006-10-20T08:44:56Z", "timestamp": 1161333896000}, "page": "S24", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ANXIOGENIC ACTIONS OF CITALOPRAM IN THE SOCIAL INTERACTION (SI) TEST IN RATS"], "prefix": "10.1097", "volume": "10", "author": [{"given": "A.", "family": "Dekeyne", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Behavioural Pharmacology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T13:59:39Z", "timestamp": 1518184779000}, "score": 38.452633, "subtitle": ["BLOCKADE BY SELECTIVE ANTAGONISTS AT SEROTONIN (5-HT)2C RECEPTORS"], "issued": {"date-parts": [[1999, 8]]}, "references-count": 0, "journal-issue": {"issue": "SUPPLEMENT 1"}, "URL": "http://dx.doi.org/10.1097/00008877-199908001-00058", "ISSN": ["0955-8810"], "issn-type": [{"value": "0955-8810", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:51:26Z", "timestamp": 1574283086594}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Pharmacology"], "published-print": {"date-parts": [[1998, 8]]}, "DOI": "10.1097/00008877-199812001-00050", "type": "journal-article", "created": {"date-parts": [[2007, 3, 22]], "date-time": "2007-03-22T07:51:05Z", "timestamp": 1174549865000}, "page": "S30", "source": "Crossref", "is-referenced-by-count": 0, "title": ["DISCRIMINATIVE STIMULUS (DS) PROPERTIES OF THE NOVEL AND POTENT SEROTONIN (5-HT)2C RECEPTOR AGONIST, RO 60???0175, IN RATS"], "prefix": "10.1097", "volume": "9", "author": [{"given": "A.", "family": "Dekeyne", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Brocco", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Girardon", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Monneyron", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Veiga", "sequence": "additional", "affiliation": []}, {"given": "M. J.", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Behavioural Pharmacology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T08:07:38Z", "timestamp": 1518163658000}, "score": 37.259636, "subtitle": [""], "issued": {"date-parts": [[1998, 8]]}, "references-count": 0, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1097/00008877-199812001-00050", "ISSN": ["0955-8810"], "issn-type": [{"value": "0955-8810", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T01:20:23Z", "timestamp": 1574299223185}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "Supplement", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Behavioural Pharmacology"], "published-print": {"date-parts": [[1998, 8]]}, "DOI": "10.1097/00008877-199808001-00050", "type": "journal-article", "created": {"date-parts": [[2007, 6, 12]], "date-time": "2007-06-12T08:03:35Z", "timestamp": 1181635415000}, "page": "S30", "source": "Crossref", "is-referenced-by-count": 1, "title": ["DISCRIMINATIVE STIMULUS (DS) PROPERTIES OF THE NOVEL AND POTENT SEROTONIN (5-HT)2C RECEPTOR AGONIST, RO 60\u20130175, IN RATS"], "prefix": "10.1097", "volume": "9", "author": [{"given": "A.", "family": "Dekeyne", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Brocco", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Girardon", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Monneyron", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Veiga", "sequence": "additional", "affiliation": []}, {"given": "M. J.", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Behavioural Pharmacology"], "language": "en", "link": [{"URL": "http://journals.lww.com/behaviouralpharm/Fulltext/10.1097/00008877-199808001-00050", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T13:20:10Z", "timestamp": 1543497610000}, "score": 37.259636, "subtitle": [""], "issued": {"date-parts": [[1998, 8]]}, "references-count": 0, "journal-issue": {"issue": "Supplement"}, "URL": "http://dx.doi.org/10.1097/00008877-199808001-00050", "ISSN": ["0955-8810"], "issn-type": [{"value": "0955-8810", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:26:32Z", "timestamp": 1574094392093}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 4]]}, "DOI": "10.1016/s0893-133x(01)00389-x", "type": "journal-article", "created": {"date-parts": [[2002, 10, 14]], "date-time": "2002-10-14T23:11:54Z", "timestamp": 1034637114000}, "page": "552-556", "source": "Crossref", "is-referenced-by-count": 16, "title": ["The Selective Serotonin2A Receptor Antagonist, MDL100,907, Elicits a Specific Interoceptive Cue in Rats"], "prefix": "10.1038", "volume": "26", "author": [{"given": "A", "family": "Dekeyne", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Neuropsychopharmacology"], "deposited": {"date-parts": [[2011, 8, 8]], "date-time": "2011-08-08T19:02:07Z", "timestamp": 1312830127000}, "score": 36.325077, "issued": {"date-parts": [[2002, 4]]}, "references-count": 0, "journal-issue": {"issue": "4"}, "alternative-id": ["S0893-133X(01)00389-X"], "URL": "http://dx.doi.org/10.1016/s0893-133x(01)00389-x", "ISSN": ["0893-133X"], "issn-type": [{"value": "0893-133X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:11:55Z", "timestamp": 1574161915379}, "reference-count": 28, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1987, 1, 1]], "date-time": "1987-01-01T00:00:00Z", "timestamp": 536457600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Physiology & Behavior"], "published-print": {"date-parts": [[1987, 1]]}, "DOI": "10.1016/0031-9384(87)90360-x", "type": "journal-article", "created": {"date-parts": [[2003, 4, 25]], "date-time": "2003-04-25T08:37:02Z", "timestamp": 1051259822000}, "page": "241-245", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Pharmacology of the pyrazolo-type compounds: Agonist, antagonist and inverse agonist actions"], "prefix": "10.1016", "volume": "41", "author": [{"given": "Debra A.", "family": "Bennett", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Physiology & Behavior"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:003193848790360X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:003193848790360X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 22]], "date-time": "2019-03-22T11:55:03Z", "timestamp": 1553255703000}, "score": 35.022984, "issued": {"date-parts": [[1987, 1]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[1987, 1]]}, "issue": "3"}, "alternative-id": ["003193848790360X"], "URL": "http://dx.doi.org/10.1016/0031-9384(87)90360-x", "ISSN": ["0031-9384"], "issn-type": [{"value": "0031-9384", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T07:55:19Z", "timestamp": 1574582119279}, "reference-count": 53, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 4, 1]], "date-time": "2015-04-01T00:00:00Z", "timestamp": 1427846400000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "Universit\u00e9 de Lyon", "award": []}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Pharmacology Biochemistry and Behavior"], "published-print": {"date-parts": [[2015, 4]]}, "DOI": "10.1016/j.pbb.2015.02.011", "type": "journal-article", "created": {"date-parts": [[2015, 2, 16]], "date-time": "2015-02-16T17:34:44Z", "timestamp": 1424108084000}, "page": "136-142", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 19, "title": ["A 5-HT3 receptor antagonist potentiates the behavioral, neurochemical and electrophysiological actions of an SSRI antidepressant"], "prefix": "10.1016", "volume": "131", "author": [{"given": "C.", "family": "B\u00e9try", "sequence": "first", "affiliation": []}, {"given": "D.", "family": "Overstreet", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Haddjeri", "sequence": "additional", "affiliation": []}, {"given": "A.L.", "family": "Pehrson", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Bundgaard", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Sanchez", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "M\u00f8rk", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacology Biochemistry and Behavior"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0091305715000520?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0091305715000520?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 20]], "date-time": "2019-08-20T23:45:19Z", "timestamp": 1566344719000}, "score": 33.87207, "issued": {"date-parts": [[2015, 4]]}, "references-count": 53, "alternative-id": ["S0091305715000520"], "URL": "http://dx.doi.org/10.1016/j.pbb.2015.02.011", "ISSN": ["0091-3057"], "issn-type": [{"value": "0091-3057", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "A 5-HT3 receptor antagonist potentiates the behavioral, neurochemical and electrophysiological actions of an SSRI antidepressant", "name": "articletitle", "label": "Article Title"}, {"value": "Pharmacology Biochemistry and Behavior", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.pbb.2015.02.011", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2015 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T19:24:16Z", "timestamp": 1574105056474}, "reference-count": 10, "publisher": "Elsevier BV", "issue": "7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1998, 7, 1]], "date-time": "1998-07-01T00:00:00Z", "timestamp": 899251200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropharmacology"], "published-print": {"date-parts": [[1998, 7]]}, "DOI": "10.1016/s0028-3908(98)00078-1", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T22:55:58Z", "timestamp": 1027637758000}, "page": "953-955", "source": "Crossref", "is-referenced-by-count": 190, "title": ["Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo"], "prefix": "10.1016", "volume": "37", "author": [{"given": "M.J", "family": "Millan", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Dekeyne", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Gobert", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuropharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0028390898000781?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0028390898000781?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T17:21:18Z", "timestamp": 1555608078000}, "score": 33.762646, "issued": {"date-parts": [[1998, 7]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[1998, 7]]}, "issue": "7"}, "alternative-id": ["S0028390898000781"], "URL": "http://dx.doi.org/10.1016/s0028-3908(98)00078-1", "ISSN": ["0028-3908"], "issn-type": [{"value": "0028-3908", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T18:14:25Z", "timestamp": 1574446465848}, "reference-count": 28, "publisher": "Springer Science and Business Media LLC", "issue": "2-3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2010, 7, 21]], "date-time": "2010-07-21T00:00:00Z", "timestamp": 1279670400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2011, 2]]}, "DOI": "10.1007/s00213-010-1928-2", "type": "journal-article", "created": {"date-parts": [[2010, 7, 20]], "date-time": "2010-07-20T04:08:42Z", "timestamp": 1279598922000}, "page": "393-401", "source": "Crossref", "is-referenced-by-count": 10, "title": ["The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B"], "prefix": "10.1007", "volume": "213", "author": [{"given": "Laura C.", "family": "Scarlota", "sequence": "first", "affiliation": []}, {"given": "John A.", "family": "Harvey", "sequence": "additional", "affiliation": []}, {"given": "Vincent J.", "family": "Aloyo", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 7, 21]]}, "reference": [{"key": "1928_CR1", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1016/j.pharmthera.2006.08.004", "volume": "113", "author": "KD Alex", "year": "2007", "unstructured": "Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296\u2013320", "journal-title": "Pharmacol Ther"}, {"issue": "3", "key": "1928_CR2", "doi-asserted-by": "crossref", "first-page": "430", "DOI": "10.1016/S0893-133X(02)00311-1", "volume": "27", "author": "S Bonaccorso", "year": "2002", "unstructured": "Bonaccorso S, Meltzer HY, Li Z, Dai J, Alboszta AR, Ichikawa J (2002) SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Neuropsychopharmacology 27(3):430\u2013441", "journal-title": "Neuropsychopharmacology"}, {"issue": "6", "key": "1928_CR3", "doi-asserted-by": "crossref", "first-page": "1597", "DOI": "10.1111/j.1471-4159.2005.03485.x", "volume": "95", "author": "A Bortolozzi", "year": "2005", "unstructured": "Bortolozzi A, D\u00edaz-Mataix L, Scorza MC, Celada P, Artigas F (2005) The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J Neurochem 95(6):1597\u20131607", "journal-title": "J Neurochem"}, {"issue": "1\u20132", "key": "1928_CR4", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1016/S0091-3057(01)00767-5", "volume": "72", "author": "KD Dave", "year": "2002", "unstructured": "Dave KD, Harvey JA, Aloyo VJ (2002) A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation. Pharmacol Biochem Behav 72(1\u20132):371\u2013378", "journal-title": "Pharmacol Biochem Behav"}, {"issue": "13", "key": "1928_CR5", "doi-asserted-by": "crossref", "first-page": "3235", "DOI": "10.1523/JNEUROSCI.0112-04.2004", "volume": "24", "author": "P Deurwaerdere De", "year": "2004", "unstructured": "De Deurwaerdere P, Navailles S, Berg KA, Clarke WP, Spampinato U (2004) Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 24(13):3235\u20133241", "journal-title": "J Neurosci"}, {"issue": "2", "key": "1928_CR6", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1016/S0306-4522(98)00655-1", "volume": "91", "author": "G Giovanni Di", "year": "1999", "unstructured": "Di Giovanni G, De Deurwaerdere P, Di Mascio M, Di Matteo V, Esposito E, Spampinato U (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91(2):587\u2013597", "journal-title": "Neuroscience"}, {"issue": "2", "key": "1928_CR7", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1007/BF00498455", "volume": "307", "author": "JR Fozard", "year": "1979", "unstructured": "Fozard JR, Palfreyman MG (1979) Metoclopramide antagonism of 5-hydroxytryptophan-induced \"wet-dog\" shake behaviour in the rat. Naunyn Schmiedebergs Arch Pharmacol 307(2):135\u2013142", "journal-title": "Naunyn Schmiedebergs Arch Pharmacol"}, {"key": "1928_CR8", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1016/S0893-133X(00)00136-6", "volume": "23", "author": "JC Gewirtz", "year": "2000", "unstructured": "Gewirtz JC, Marek GJ (2000) Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors. Neuropsychopharm 23:569\u2013576", "journal-title": "Neuropsychopharm"}, {"issue": "2", "key": "1928_CR9", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1016/S0028-3908(98)00188-9", "volume": "38", "author": "A Gobert", "year": "1999", "unstructured": "Gobert A, Millan MJ (1999) Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38(2):315\u2013317", "journal-title": "Neuropharmacology"}, {"issue": "3", "key": "1928_CR10", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1002/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D", "volume": "36", "author": "A Gobert", "year": "2000", "unstructured": "Gobert A, Rivet JM, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas JP, Cistarelli L, Melon C, Millan M (2000) Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36(3):205\u2013221", "journal-title": "Synapse"}, {"issue": "2", "key": "1928_CR11", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/S0149-7634(98)00024-4", "volume": "23", "author": "FG Graeff", "year": "1998", "unstructured": "Graeff FG, Netto CF, Zangrossi H Jr (1998) The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23(2):237\u2013246", "journal-title": "Neurosci Biobehav Rev"}, {"issue": "1", "key": "1928_CR12", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1111/j.1476-5381.1983.tb11063.x", "volume": "80", "author": "AR Green", "year": "1983", "unstructured": "Green AR, Johnson P, Nimgaonkar VL (1983) Increased 5-HT2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats. Br J Pharmacol 80(1):173\u2013177", "journal-title": "Br J Pharmacol"}, {"issue": "3", "key": "1928_CR13", "doi-asserted-by": "crossref", "first-page": "1023", "DOI": "10.1124/jpet.106.113357", "volume": "320", "author": "EA Hackler", "year": "2007", "unstructured": "Hackler EA, Turner GH, Gresch PJ, Sengupta S, Deutch AY, Avison MJ, Gore JC, Sanders-Bush E (2007) 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation. J Pharmacol Exp Ther 320(3):1023\u20131029", "journal-title": "J Pharmacol Exp Ther"}, {"issue": "3", "key": "1928_CR14", "doi-asserted-by": "crossref", "first-page": "797", "DOI": "10.1111/j.1476-5381.1994.tb14808.x", "volume": "111", "author": "GA Kennett", "year": "1994", "unstructured": "Kennett GA, Wood MD, Glen A, Grewal S, Forbes I, Gadre A, Blackburn TP (1994) In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist. Br J Pharmacol 111(3):797\u2013802", "journal-title": "Br J Pharmacol"}, {"issue": "3", "key": "1928_CR15", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1111/j.1476-5381.1996.tb15208.x", "volume": "117", "author": "GA Kennett", "year": "1996", "unstructured": "Kennett GA, Wood MD, Bright F, Cilia J, Piper DC, Gager T, Thomas D, Baxter GS, Forbes IT, Ham P, Blackburn TP (1996) In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. Br J Pharmacol 117(3):427\u2013434", "journal-title": "Br J Pharmacol"}, {"issue": "7", "key": "1928_CR16", "doi-asserted-by": "crossref", "first-page": "953", "DOI": "10.1016/S0028-3908(98)00078-1", "volume": "37", "author": "MJ Millan", "year": "1998", "unstructured": "Millan MJ, Dekeyne A, Gobert A (1998) Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37(7):953\u2013955", "journal-title": "Neuropharmacology"}, {"issue": "4", "key": "1928_CR17", "doi-asserted-by": "crossref", "first-page": "1051", "DOI": "10.1016/S0091-3057(97)00057-9", "volume": "58", "author": "PO Mora", "year": "1997", "unstructured": "Mora PO, Netto CF, Graeff FG (1997) Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze. Pharmacol Biochem Behav 58(4):1051\u20131057", "journal-title": "Pharmacol Biochem Behav"}, {"issue": "2", "key": "1928_CR18", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1007/s00213-004-2044-y", "volume": "179", "author": "BA Nic Dhonnchadha", "year": "2005", "unstructured": "Nic Dhonnchadha BA, Ripoll N, Clenet F, Hascoet M, Bourin M (2005) Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test. Psychopharmacology (Berl) 179(2):418\u2013429", "journal-title": "Psychopharmacology (Berl)"}, {"issue": "2", "key": "1928_CR19", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1038/sj.npp.1300819", "volume": "31", "author": "EA Pehek", "year": "2006", "unstructured": "Pehek EA, Nocjar C, Roth BL, Byrd TA, Mabrouk OS (2006) Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 31(2):265\u2013277", "journal-title": "Neuropsychopharmacology"}, {"issue": "2", "key": "1928_CR20", "first-page": "759", "volume": "262", "author": "M Rinaldi-Carmona", "year": "1992", "unstructured": "Rinaldi-Carmona M, Congy C, Santucci V, Simiand J, Gautret B, Neliat G, Labeeuw B, Le Fur G, Soubrie P, Breliere JC (1992) Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist. J Pharmacol Exp Ther 262(2):759\u2013768", "journal-title": "J Pharmacol Exp Ther"}, {"issue": "1", "key": "1928_CR21", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/j.bbr.2005.07.013", "volume": "166", "author": "N Ripoll", "year": "2006", "unstructured": "Ripoll N, Hascoet M, Bourin M (2006) Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice. Behav Brain Research 166(1):131\u2013139", "journal-title": "Behav Brain Research"}, {"issue": "4", "key": "1928_CR22", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1038/nrd1346", "volume": "3", "author": "BL Roth", "year": "2004", "unstructured": "Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3(4):353\u2013359", "journal-title": "Nat Rev Drug Discov"}, {"issue": "1", "key": "1928_CR23", "first-page": "101", "volume": "273", "author": "R Schreiber", "year": "1995", "unstructured": "Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ (1995) (1-(2, 5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 273(1):101\u2013112", "journal-title": "J Pharmacol Exp Ther"}, {"key": "1928_CR24", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1111/j.1749-6632.1998.tb09759.x", "volume": "846", "author": "KJ Simansky", "year": "1998", "unstructured": "Simansky KJ, Baker G, Kachelries WJ, Hood H, Romano AG, Harvey JA (1998) Prenatal exposure to cocaine reduces dopaminergic D1-mediated motor function but spares the enhancement of learning by amphetamine in rabbits. Ann N Y Acad Sci 846:375\u2013378", "journal-title": "Ann N Y Acad Sci"}, {"issue": "3", "key": "1928_CR25", "doi-asserted-by": "crossref", "first-page": "949", "DOI": "10.1016/j.neuropharm.2006.10.012", "volume": "52", "author": "O Stiedl", "year": "2007", "unstructured": "Stiedl O, Misane I, Koch M, Pattij T, Meyer M, Ogren SO (2007) Activation of the brain 5-HT2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice. Neuropharmacology 52(3):949\u2013957", "journal-title": "Neuropharmacology"}, {"issue": "6", "key": "1928_CR26", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.2174/1568007033482698", "volume": "2", "author": "MD Wood", "year": "2003", "unstructured": "Wood MD (2003) Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders. Curr Drug Targets CNS Neurol Disord 2(6):383\u2013387", "journal-title": "Curr Drug Targets CNS Neurol Disord"}, {"key": "1928_CR27", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1016/S0079-6123(08)00911-4", "volume": "172", "author": "MD Wood", "year": "2008", "unstructured": "Wood MD, Wren PB (2008) Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders. Prog Brain Res 172:213\u2013230", "journal-title": "Prog Brain Res"}, {"issue": "4", "key": "1928_CR28", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1016/j.pbb.2007.09.009", "volume": "88", "author": "A Yonezawa", "year": "2008", "unstructured": "Yonezawa A, Yoshizumi M, Ebiko M, Ise SN, Watanabe C, Mizoguchi H, Kimura Y, Sakurada S (2008) Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes. Pharmacol Biochem Behav 88(4):367\u2013373", "journal-title": "Pharmacol Biochem Behav"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00213-010-1928-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00213-010-1928-2/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00213-010-1928-2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T20:07:16Z", "timestamp": 1558642036000}, "score": 32.65657, "issued": {"date-parts": [[2010, 7, 21]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[2011, 2]]}, "issue": "2-3"}, "alternative-id": ["1928"], "URL": "http://dx.doi.org/10.1007/s00213-010-1928-2", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:40:00Z", "timestamp": 1574217600533}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 9, 1]], "date-time": "2006-09-01T00:00:00Z", "timestamp": 1157068800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropharmacology"], "published-print": {"date-parts": [[2006, 9]]}, "DOI": "10.1016/j.neuropharm.2006.05.012", "type": "journal-article", "created": {"date-parts": [[2006, 7, 4]], "date-time": "2006-07-04T11:13:10Z", "timestamp": 1152011590000}, "page": "718-726", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Discriminative stimulus properties of the selective and highly potent \u03b12-adrenoceptor agonist, S18616, in rats: Mediation by the \u03b12A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin"], "prefix": "10.1016", "volume": "51", "author": [{"given": "A", "family": "DEKEYNE", "sequence": "first", "affiliation": []}, {"given": "M", "family": "MILLAN", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuropharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0028390806001377?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0028390806001377?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 15]], "date-time": "2019-01-15T10:22:01Z", "timestamp": 1547547721000}, "score": 32.490273, "issued": {"date-parts": [[2006, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 9]]}, "issue": "4"}, "alternative-id": ["S0028390806001377"], "URL": "http://dx.doi.org/10.1016/j.neuropharm.2006.05.012", "ISSN": ["0028-3908"], "issn-type": [{"value": "0028-3908", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T22:09:24Z", "timestamp": 1575238164402}, "reference-count": 0, "publisher": "Oxford University Press", "isbn-type": [{"value": "9780195367294", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010, 6]]}, "DOI": "10.1093/med/9780195367294.003.0463", "type": "book-chapter", "created": {"date-parts": [[2013, 6, 20]], "date-time": "2013-06-20T09:40:29Z", "timestamp": 1371721229000}, "page": "171-184", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The Serotonin 2C Receptor Gene"], "prefix": "10.1093", "author": [{"given": "David A.", "family": "Mrazek", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["Psychiatric Pharmacogenomics"], "deposited": {"date-parts": [[2017, 11, 7]], "date-time": "2017-11-07T13:30:29Z", "timestamp": 1510061429000}, "score": 32.22906, "issued": {"date-parts": [[2010, 6]]}, "ISBN": ["9780195367294"], "references-count": 0, "URL": "http://dx.doi.org/10.1093/med/9780195367294.003.0463"}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T13:30:06Z", "timestamp": 1574861406489}, "reference-count": 0, "publisher": "Worldwide Protein Data Bank", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.2210/pdb5ojt/pdb", "type": "component", "created": {"date-parts": [[2017, 11, 21]], "date-time": "2017-11-21T19:04:11Z", "timestamp": 1511291051000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Structure-Activity Relationships and Biological Characterization of a Novel, Potent and Serum Stable C-X-C chemokine receptor type 4 (CXCR4) Antagonist"], "prefix": "10.2210", "author": [{"given": "D.", "family": "Brancaccio", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Carotenuto", "sequence": "additional", "affiliation": []}], "member": "7763", "published-online": {"date-parts": [[2017, 11, 22]]}, "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T22:30:44Z", "timestamp": 1569882644000}, "score": 32.187828, "issued": {"date-parts": [[2017, 11, 22]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2210/pdb5ojt/pdb"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:09:48Z", "timestamp": 1574154588221}, "reference-count": 64, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 4, 1]], "date-time": "2003-04-01T00:00:00Z", "timestamp": 1049155200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropharmacology"], "published-print": {"date-parts": [[2003, 4]]}, "DOI": "10.1016/s0028-3908(03)00040-6", "type": "journal-article", "created": {"date-parts": [[2003, 4, 7]], "date-time": "2003-04-07T18:47:43Z", "timestamp": 1049741263000}, "page": "604-615", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907"], "prefix": "10.1016", "volume": "44", "author": [{"given": "A", "family": "Dekeyne", "sequence": "first", "affiliation": []}, {"given": "L", "family": "Iob", "sequence": "additional", "affiliation": []}, {"given": "M.J", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuropharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0028390803000406?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0028390803000406?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 27]], "date-time": "2019-03-27T05:22:26Z", "timestamp": 1553664146000}, "score": 31.085432, "issued": {"date-parts": [[2003, 4]]}, "references-count": 64, "journal-issue": {"published-print": {"date-parts": [[2003, 4]]}, "issue": "5"}, "alternative-id": ["S0028390803000406"], "URL": "http://dx.doi.org/10.1016/s0028-3908(03)00040-6", "ISSN": ["0028-3908"], "issn-type": [{"value": "0028-3908", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T23:08:17Z", "timestamp": 1574291297877}, "reference-count": 52, "publisher": "Elsevier BV", "issue": "1-3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 7, 1]], "date-time": "2007-07-01T00:00:00Z", "timestamp": 1183248000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[2007, 7]]}, "DOI": "10.1016/j.ejphar.2007.04.030", "type": "journal-article", "created": {"date-parts": [[2007, 5, 7]], "date-time": "2007-05-07T14:23:16Z", "timestamp": 1178547796000}, "page": "45-53", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Serotonin 5-HT2C receptor homodimerization is not regulated by agonist or inverse agonist treatment"], "prefix": "10.1016", "volume": "568", "author": [{"given": "Katharine", "family": "Herrick-Davis", "sequence": "first", "affiliation": []}, {"given": "Ellinor", "family": "Grinde", "sequence": "additional", "affiliation": []}, {"given": "Barbara A.", "family": "Weaver", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0014299907004657?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0014299907004657?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 27]], "date-time": "2019-04-27T19:05:57Z", "timestamp": 1556391957000}, "score": 30.742687, "issued": {"date-parts": [[2007, 7]]}, "references-count": 52, "journal-issue": {"published-print": {"date-parts": [[2007, 7]]}, "issue": "1-3"}, "alternative-id": ["S0014299907004657"], "URL": "http://dx.doi.org/10.1016/j.ejphar.2007.04.030", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:33:03Z", "timestamp": 1574415183376}, "publisher-location": "Berlin, Heidelberg", "reference-count": 19, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642714207", "type": "print"}, {"value": "9783642714184", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1986]]}, "DOI": "10.1007/978-3-642-71418-4_3", "type": "book-chapter", "created": {"date-parts": [[2011, 11, 4]], "date-time": "2011-11-04T14:02:51Z", "timestamp": 1320415371000}, "page": "25-32", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Characterization of Adrenoceptors: Receptor-Binding Studies and Agonist-Antagonist Interaction"], "prefix": "10.1007", "author": [{"given": "A.", "family": "Wellstein", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "3_CR1", "doi-asserted-by": "crossref", "first-page": "586", "DOI": "10.1152/ajplegacy.1948.153.3.586", "volume": "153", "author": "RP Ahlquist", "year": "1948", "unstructured": "Ahlquist RP (1948) A study of ad re not ro pic receptors. Am J Physiol 153: 586\u2013600", "journal-title": "Am J Physiol"}, {"key": "3_CR2", "doi-asserted-by": "publisher", "first-page": "2189", "DOI": "10.1016/0024-3205(81)90490-2", "volume": "29", "author": "OE Brodde", "year": "1981", "unstructured": "Brodde OE, Engel G, Hover D, Bcck KD, Weber F (1981) The \u03b2 -adrcnergic receptor in human lymphocytes: Subclassificationby the use of a new radio-ligand, (+/-) 125-iodocyanopindolol. Life Sci 29: 2189\u20132198", "journal-title": "Life Sci"}, {"key": "3_CR3", "unstructured": "Furchgott RF(1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (cds) Catecholamines. Springer, Berlin Heidelberg New York, pp 283-335\u00bb Handbook of experimental pharmacology, vol 33"}, {"key": "3_CR4", "first-page": "211", "volume": "9", "author": "JH Gaddum", "year": "1957", "unstructured": "Gaddum JH (1957) Theories of drug antagonism. Pharmacol Rev 9: 211\u2013218", "journal-title": "Pharmacol Rev"}, {"key": "3_CR5", "doi-asserted-by": "publisher", "first-page": "379", "DOI": "10.1007/BF00508412", "volume": "289", "author": "D Gauger", "year": "1975", "unstructured": "Gauger D, Kaiser G, Quiring K, Palm D (1975) The \u03b2-acrenergic receptor adenyl cyclase-system of rat reticulocytes. Naunyn-Schmiedebergs.Arch Pharmacol 289: 379\u2013389", "journal-title": "Naunyn-Schmiedebergs.Arch Pharmacol"}, {"key": "3_CR6", "author": "CF Gauss", "first-page": "I", "year": "1809", "unstructured": "Gauss CF (1809) Theoria motus corporum coelestium in sectionibus conicis solern ambientiurn. Lib II, Sect I II, Hamburgi Sumtibus, Fnd Perthes et IH Bcsscr", "volume-title": "Theoria motus corporum coelestium in sectionibus conicis solern ambientiurn. Lib II, Sect"}, {"key": "3_CR7", "author": "E Gille", "first-page": "331", "year": "1985", "unstructured": "Gille E, Lemoine H, Ehle B, Kallmann AJ (1985) The affinity of (-)-propranolol for \u03b21- and \u03b22-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn-Schmiede bergs Arch Pharmacol 331: 60\u201370", "volume-title": "The affinity of (-)-propranolol for \u03b21- and \u03b22-adrenoceptors of human heart"}, {"key": "3_CR8", "first-page": "597", "volume": "214", "author": "PM Laduron", "year": "1984", "unstructured": "Laduron PM (1984) Criteria for receptor sites in binding studies. Biochem Pharmacol 33: 833\u20138399. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967 a) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214: 597\u2013598", "journal-title": "Criteria for receptor sites in binding studies. Biochem Pharmacol 33: 833\u20138399. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967 a) Differentiation of receptor systems activated by sympathomimetic amines. Nature"}, {"key": "3_CR9", "doi-asserted-by": "crossref", "first-page": "2241", "DOI": "10.1016/0024-3205(67)90031-8", "volume": "6", "author": "AM Lands", "year": "1967", "unstructured": "Lands AM, Luduena FP, Buzzo HJ (1967 b) Differentiation of receptors responsive to isoproterenol. Life Sci 6: 2241\u20132249", "journal-title": "Life Sci"}, {"key": "3_CR10", "doi-asserted-by": "publisher", "first-page": "159", "DOI": "10.1146/annurev.bi.52.070183.001111", "volume": "52", "author": "RJ Lefkowitz", "year": "1983", "unstructured": "Lefkowitz RJ, Stadel JM, Caron MG (1983) Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. Annu Rev Biochem 52: 159\u2013186", "journal-title": "Annu Rev Biochem"}, {"key": "3_CR11", "author": "HJ Motulsky", "first-page": "307", "year": "1982", "unstructured": "Motulsky HJ, Insel PA (1982) Adrenergic receptors in man. Direct identification, physiologic regulation, and clinical alterations. N Engl J Med 307: 18\u201329", "volume-title": "Adrenergic receptors in man"}, {"key": "3_CR12", "author": "D Palm", "first-page": "28", "year": "1985", "unstructured": "Palm D, Wellstein A (1985) Multipotente Arzneistoffe - Hybride und Pseudohybride. In: Holzgreve H (ed) Kombinierte Alpha- und Beta-Adrenozeptorenblockade mit symbiontischen Molek\u00fclen. Ein neues Therapiekonzept bei Hypertonie und koronarer Herzkrankheit. MMW Medizin Verlag, M\u00fcnchen, pp 28\u201356", "volume-title": "Kombinierte Alpha- und Beta-Adrenozeptorenblockade mit symbiontischen Molek\u00fclen. Ein neues Therapiekonzept bei Hypertonie und koronarer Herzkrankheit"}, {"key": "3_CR13", "doi-asserted-by": "publisher", "first-page": "660", "DOI": "10.1111/j.1749-6632.1949.tb27297.x", "volume": "51", "author": "G Scatchard", "year": "1949", "unstructured": "Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660\u2013672", "journal-title": "Ann NY Acad Sci"}, {"key": "3_CR14", "first-page": "3496", "volume": "258", "author": "M Staehelin", "year": "1983", "unstructured": "Staehelin M, Simons P, Jaeggi K, Wigger N (1983) CGP12177. A hydrophilic \u03b2-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 258: 3496\u20133502", "journal-title": "J Biol Chem"}, {"key": "3_CR15", "author": "HM Hattingberg Von", "first-page": "11", "year": "1977", "unstructured": "Von Hattingberg HM, Brockmeier D, Kreuter G (1977) A rotating iterative procedure ( RIP) for estimating hybrid constants. Eur J Clin Pharmacol 11: 381\u2013388", "volume-title": "A rotating iterative procedure"}, {"key": "3_CR16", "doi-asserted-by": "publisher", "first-page": "545", "DOI": "10.1007/BF00556890", "volume": "27", "author": "A Wellstein", "year": "1984", "unstructured": "Wellstein A, Palm D, Wiemer G, Sch\u00e4fer-K\u00f6rting M, Mutschier E (1984) Simple and reliable radioreceptor assay for \u03b2-adrenoceptor antagonists and active metabolites in native human plasma. Eur J Clin Pharmacol 27: 545\u2013553", "journal-title": "Eur J Clin Pharmacol"}, {"key": "3_CR17", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1007/BF00547412", "volume": "29", "author": "A Wellstein", "year": "1985", "unstructured": "Wellstein A, Palm D, Beiz GG, Pitschner HF (1985) Receptor binding of propranolol is the missing link between plasma concentration kinetics and effect time course in man. Eur J Clin Pharmacol 29: 131\u2013147", "journal-title": "Eur J Clin Pharmacol"}, {"key": "3_CR18", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1007/BF00586342", "volume": "321", "author": "G Wiemer", "year": "1982", "unstructured": "Wiemer G, Wellstein A, Palm D, von Hattingberg HM, Brockmeier D (1982) Properties of agonist binding at the \u03b2-adrenoceptor of the rat reticulocyte. Naunyn-Schmiedebergs Arch Pharmacol 321: 11\u201319", "journal-title": "Naunyn-Schmiedebergs Arch Pharmacol"}, {"key": "3_CR19", "author": "LT Williams", "year": "1978", "unstructured": "Williams LT, Lefkowitz RJ (1978) Receptor binding in adrenergic pharmacology. Raven, New York", "volume-title": "Receptor binding in adrenergic pharmacology"}], "container-title": ["New Aspects in Hypertension Adrenoceptors"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-71418-4_3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T22:11:12Z", "timestamp": 1572905472000}, "score": 30.622293, "issued": {"date-parts": [[1986]]}, "ISBN": ["9783642714207", "9783642714184"], "references-count": 19, "URL": "http://dx.doi.org/10.1007/978-3-642-71418-4_3", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:35:05Z", "timestamp": 1574094905626}, "reference-count": 3, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2000, 9, 1]], "date-time": "2000-09-01T00:00:00Z", "timestamp": 967766400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2000, 9]]}, "DOI": "10.1016/s0924-977x(00)80132-7", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T12:16:31Z", "timestamp": 1027599391000}, "page": "217", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The differential reinforcement of low-rate (DRL) 72 model for characterization of antidepressant agents: Noradrenaline, but not serotonin or dopamine, uptake inhibitors mimic the actions of imipramine"], "prefix": "10.1016", "volume": "10", "author": [{"given": "A.", "family": "Dekeyne", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Adhumeau-Auclair", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Girardon", "sequence": "additional", "affiliation": []}, {"given": "M.J.", "family": "Millan", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X00801327?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X00801327?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 30]], "date-time": "2019-04-30T21:27:12Z", "timestamp": 1556659632000}, "score": 30.59195, "issued": {"date-parts": [[2000, 9]]}, "references-count": 3, "alternative-id": ["S0924977X00801327"], "URL": "http://dx.doi.org/10.1016/s0924-977x(00)80132-7", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}